ROCKVILLE, Md., April 1, 2014 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases, today announced that Jim Karrels, Vice President and Chief Financial Officer, and Eric Risser, Vice President of Business Development, will present at the 13th Annual Needham Healthcare Conference. The presentation will take place Tuesday, April 8, 2014, at 5:00 p.m. Eastern Time in New York.
Help employers find you! Check out all the jobs and post your resume.
